The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

The loss of Novo’s involvement significantly dented investor confidence in Hims & Hers, plunging shares in the latter by 35% ...

Here are five key things investors need to know to start the trading day: 1. Market reaction. Stocks rose Monday as investors ...

Iran, Israel cease-fire gets off to a fragile start, Compass sues Zillow in real estate rift, nuclear firm Holtec could go ...

Stock markets have rallied after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...

Novo Nordisk drops Hims & Hers because it was selling and promoting a cheaper copycat of Wegovy, its weight loss drug.